SpeeDx: Funding, Investors & Team (Oct 2026)
SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease.
SpeeDx has raised $1.8M across 1 funding round on record, the most recent an undisclosed round of $1.8M announced in May 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SpeeDx Company Profile and Key Stats
Latest funding round on record: May 2021.
SpeeDx Funding Rounds
SpeeDx Founders and Leadership Team
No contact details are on record for this team yet.
SpeeDx Funding Compared to Other Biotechnology Startups
SpeeDx's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SpeeDx in Biotechnology and Sydney
Companies Similar to SpeeDx
Kinoxis Therapeutics, an emerging biotechnology company located in Australia, is focused on advancing the…
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
SpeeDx Funding FAQs
What does SpeeDx do?
SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease.
How much funding has SpeeDx raised?
SpeeDx has raised $1.8M across 1 round on record. The most recent is an undisclosed round of $1.8M announced in May 2021.
When did SpeeDx last raise funding?
SpeeDx's most recent funding round on record is an undisclosed round of $1.8M, announced in May 2021.
Who is the CEO of SpeeDx?
Colin Denver is listed as CEO at SpeeDx.
Where is SpeeDx headquartered?
SpeeDx is based in Sydney, New South Wales, Australia.
How many employees does SpeeDx have?
SpeeDx is in the 51-100 employee band.
How does SpeeDx's funding compare to other Biotechnology startups?
SpeeDx's latest round of $1.8M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's SpeeDx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SpeeDx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.